# Association of regional specificity of blood-brain barrier permeability with pathological subtypes in cerebral white matter of patients with non-brain metastatic lung cancer

**Authors:** Haotian Wang, Jian Zeng, Zhengzhen Li, Yonglong Li, Yi Wang, Xiufu Zhang, Jun Zhou, Hongying Liu, Chunrong Wu, Ruipeng Liang

PMC · DOI: 10.3389/fonc.2026.1717244 · Frontiers in Oncology · 2026-02-23

## TL;DR

This study shows that lung cancer patients without brain metastases still have blood-brain barrier issues, and these issues vary by cancer subtype, especially in white matter regions of the brain.

## Contribution

The study reveals regional BBB permeability differences in non-brain metastatic lung cancer patients, linked to specific histopathological subtypes.

## Key findings

- Adenocarcinoma (ADC) lung cancer shows higher BBB permeability in deep white matter and posterior periventricular regions compared to other subtypes.
- Small Cell Lung Cancer (SCLC) exhibits distinct patterns of interstitial disruption, primarily in deep white matter regions.
- BBB permeability in lung cancer patients is comparable to those with brain metastases but distinct from healthy controls.

## Abstract

To investigate blood-brain barrier (BBB) permeability abnormalities in cerebral white matter regions of non-brain metastatic lung cancer (LC) patients and their association with histopathological subtypes.

221 subjects (74 Healthy Controls [HC], 78 LC, 69 LC with Brain Metastasis [LCBM]) were enrolled. LC was subdivided into Adenocarcinoma (ADC), Squamous Cell Carcinoma (SCC), Small Cell Lung Cancer (SCLC). Dynamic Contrast-Enhanced MRI (DCE-MRI) assessed Ktrans, Kep, Ve, Vp in deep (frontal/parietal/temporal/occipital lobes) and periventricular (anterior/posterior horns) white matter. Non-parametric tests were used (p<0.05 significant).

LC group had Ktrans comparable to LCBM but higher than HC (p<0.05), mainly in deep white matter and posterior periventricular regions (anterior periventricular: p>0.05). ADC showed higher Ktrans, Kep, Vp than SCC (all p<0.001) and SCLC (Ktrans/Kep p<0.001; Vp p=0.71); Ve was lower than SCLC (p=0.003) but higher than SCC (p=0.001). SCLC had higher Ve than SCC (p<0.0001), with higher Ktrans/Vp than SCC (p<0.01). Vp correlated positively with Ktrans in ADC/SCC (r=0.433/0.359, p<0.001), not in SCLC.

LC impairs BBB integrity via paraneoplastic effects, with subtype heterogeneity: ADC (high perfusion/leakage) involves global white matter; SCLC (prominent interstitial disruption) affects mainly deep regions. Findings aid LC brain metastasis risk stratification and neuroprotective strategies.

## Linked entities

- **Diseases:** lung cancer (MONDO:0005138), Adenocarcinoma (MONDO:0004970), Squamous Cell Carcinoma (MONDO:0005096), Small Cell Lung Cancer (MONDO:0008433)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}
- **Diseases:** paraneoplastic (MESH:D010257), SCC (MESH:D002294), disorders (MESH:D009358), NSCLC (MESH:D002289), inability to concentrate (MESH:C567712), multisystem dysfunction (MESH:D019578), cerebral white matter injury (MESH:D056784), Metastatic lesions (MESH:D000092182), traumatic brain injury (MESH:D000070642), BBB abnormalities (MESH:C536830), Central nervous system space-occupying lesions (MESH:D002493), neuroinflammation (MESH:D000090862), hippocampal atrophy (MESH:D001284), anxiety (MESH:D001007), cognitive abnormalities (MESH:D060825), LC (MESH:D008175), pulmonary lesions (MESH:D008171), ADC (MESH:D000230), Cancer (MESH:D009369), cognitive-pain (MESH:D010146), SCLC (MESH:D055752), HL (MESH:C538324), inflammatory (MESH:D007249), cognitive impairment (MESH:D003072), brain metastases (MESH:D001932), memory impairment (MESH:D008569), cancer pain (MESH:D000072716), neuropathic pain (MESH:D009437), depression (MESH:D003866), cerebral infarction (MESH:D002544), Cerebral hemorrhage (MESH:D002543), Brain Metastasis (MESH:D009362), Ve (MESH:C538347)
- **Chemicals:** Vp (MESH:C038467), bevacizumab (MESH:D000068258), crizotinib (MESH:D000077547), edaravone (MESH:D000077553), osimertinib (MESH:C000596361), sodium chloride (MESH:D012965), glucose (MESH:D005947), gadobutrol (MESH:C090600), DCE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968021/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968021/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968021/full.md

---
Source: https://tomesphere.com/paper/PMC12968021